Expedeon AG announced the introduction of five new Alexa Fluor® labels to its range of Lightning-Link® antibody labelling kits. The addition further expands Expedeon’s range of labels, offering customers increased choice and flexibility for common fluorescence detection based applications.
The use of secondary antibodies within fluorescent imaging applications is commonly associated with issues such as high background fluorescence and non-specific binding. The combination of Alexa Fluor labels with Lightning-Link technology overcomes these problems, by enabling easy, direct conjugation of the label to primary antibodies in less than 20 minutes. The Lightning-Link protocol is free of separation steps, saving researchers time and precious materials.
The introduction of five new dyes to the range follows the successful launch of the Alexa Fluor 488 kit in Q2 2017. The new Alexa dyes include: 647, 700, 555, 568, and 694. More information can be found here: https://www.expedeon.com/lightning-link-alexa-fluor-antibody-labeling-kits/
Dr. Heikki Lanckriet, CEO and CSO of Expedeon, said: “Uniting the leading fluorescent labels with the world’s easiest to use primary antibody labeling technology forms part of our strategy to maximise the impact of our core technologies. The new kits will help to simplify processes and increase efficiency in the lab, making a great difference to many researchers.”